RxDoctor Payments Data

Leslie Soto Velez

Pediatrics · San Juan, PRNPI 1518153287

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $250,268 of the $273,985 with a category attached, or 91.3%. Novo Nordisk accounts for 60.7% of it on its own, with 13 other manufacturers making up the rest. Among pediatrics clinicians in PR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$273,985in general payments, 2019–2025

Across 190 payments — averaging $1442.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$166K
  • Sanofi$55K
  • Bayer$42K
  • Genentech USA, Inc.$8K
  • Pfizer$3K
  • Adaptive Biotechnologies Corporation$237
  • plus $627 from 8 others

What the payments were for

  • Consulting fees$5,9352%
  • Speaking & faculty fees$250,26891%
  • Travel & lodging$12,9535%
  • Food & beverage$4,8042%
  • Education$250%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$273,985 in reported general payments places this provider in the 95th percentile of 646 pediatrics providers in Puerto Rico.

See all pediatrics providers in Puerto Rico

Other pediatrics in San Juan

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →